131 related articles for article (PubMed ID: 36716258)
21. Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer?
Yang XY; Hu Q
J Surg Oncol; 2023 Jul; 128(1):179-180. PubMed ID: 37171111
[No Abstract] [Full Text] [Related]
22. Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
Healey Bird BRJ
Br J Surg; 2020 Dec; 107(13):1705-1707. PubMed ID: 33104240
[No Abstract] [Full Text] [Related]
23. [Clinical factors of pathological complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Sha YJ; Wu HT; Wen XY; Wang CB
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(11):859-863. PubMed ID: 32234159
[No Abstract] [Full Text] [Related]
24. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?
Perez RO; Habr-Gama A; Pereira GV; Lynn PB; Alves PA; Proscurshim I; Rawet V; Gama-Rodrigues J
Colorectal Dis; 2012 Jun; 14(6):714-20. PubMed ID: 22568644
[TBL] [Abstract][Full Text] [Related]
25. Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer.
Strous MTA; Faes TKE; Heemskerk J; Lohman BGPM; Simons PCG; Janssen Heijnen MLG; Vogelaar FJ; de Bruïne AP
Surg Oncol; 2022 Dec; 45():101862. PubMed ID: 36332556
[TBL] [Abstract][Full Text] [Related]
26. [Choice of neoadjuvant therapy for rectal cancer: simple chemotherapy or synchronous chemoradiotherapy].
Li J; Deng Y; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):627-631. PubMed ID: 29968236
[TBL] [Abstract][Full Text] [Related]
27. When Should We Expect Curative Results of Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients?
Georgescu MT; Patrascu T; Serbanescu LG; Anghel RM; Gales LN; Georgescu FT; Mitrica RI; Georgescu DE
Chirurgia (Bucur); 2021; 116(1):16-23. PubMed ID: 33638322
[TBL] [Abstract][Full Text] [Related]
28. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Ryan R; Gibbons D; Hyland JM; Treanor D; White A; Mulcahy HE; O'Donoghue DP; Moriarty M; Fennelly D; Sheahan K
Histopathology; 2005 Aug; 47(2):141-6. PubMed ID: 16045774
[TBL] [Abstract][Full Text] [Related]
29. Predictive factors of complete pathological response in patients with locally advanced rectal cancer.
Engel RM; Oliva K; Koulis C; Yap R; McMurrick PJ
Int J Colorectal Dis; 2020 Sep; 35(9):1759-1767. PubMed ID: 32474708
[TBL] [Abstract][Full Text] [Related]
30. Changing patterns of neoadjuvant therapy for locally advanced rectal cancer: A narrative review.
He W; Li Q; Li X
Crit Rev Oncol Hematol; 2023 Jan; 181():103885. PubMed ID: 36464124
[TBL] [Abstract][Full Text] [Related]
31. [Neoadjuvant treatment as a limiting factor to rectal ultrasonography].
Fábián A; Bor R; Bálint A; Farkas K; Milassin Á; Rutka M; Tiszlavicz L; Nagy F; Molnár T; Szepes Z
Orv Hetil; 2016 Jul; 157(30):1193-7. PubMed ID: 27452069
[TBL] [Abstract][Full Text] [Related]
32. Endorectal ultrasonography performance in staging rectal cancer before and after neoadjuvant chemoradiotherapy.
Panzironi G; Guerrieri D; De Cristofaro F; Bangrazi C; Di Paola C; Jafari L; Fiore F; Masoni L
Ann Ital Chir; 2014; 85(6):569-75. PubMed ID: 25711540
[TBL] [Abstract][Full Text] [Related]
33. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.
Smith FM; Wiland H; Mace A; Pai RK; Kalady MF
Dis Colon Rectum; 2014 Mar; 57(3):311-5. PubMed ID: 24509452
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
[TBL] [Abstract][Full Text] [Related]
35. A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Dalle Fratte C; Mezzalira S; Polesel J; De Mattia E; Palumbo A; Buonadonna A; Palazzari E; De Paoli A; Belluco C; Canzonieri V; Toffoli G; Cecchin E
Oncol Res; 2022 Jan; 28(9):847-855. PubMed ID: 34108073
[TBL] [Abstract][Full Text] [Related]
36. [Predictive factors of pathological complete response after neoadjuvant chemoradiotherapy for middle-low rectal cancer].
Liu QZ; Zhang H; Hao LQ; Lou Z; Liu LJ; Gao XH; Gong HF; Hong YG; Xin C; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1159-1163. PubMed ID: 33353270
[No Abstract] [Full Text] [Related]
37. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
[TBL] [Abstract][Full Text] [Related]
38. Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
Ryan JE; Warrier SK; Lynch AC; Ramsay RG; Phillips WA; Heriot AG
Colorectal Dis; 2016 Mar; 18(3):234-46. PubMed ID: 26531759
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of risk factor for prognosis of patients with rectal cancer with neoadjuvant chemoradiotherapy after pathological complete remission].
Zhang H; Sun G; Zheng K; Meng RG; Hao LQ; Liu LJ; Lou Z; Gao XH; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):305-311. PubMed ID: 32192312
[No Abstract] [Full Text] [Related]
40. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]